期刊
NATURE MEDICINE
卷 18, 期 11, 页码 1639-+出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nm.2919
关键词
-
资金
- Cancer Prevention Research Institute of Texas
- McNair Medical Institute
- US National Institutes of Health [CA102463]
- New Jersey Commission on Cancer Research [06-2419-CCR-EO]
- US Department of Defense [W81XWH-07-1-0407, W81XWH06-1-0514]
Doxorubicin is believed to cause dose-dependent cardiotoxicity through redox cycling and the generation of reactive oxygen species (ROS). Here we show that cardiomyocyte-specific deletion of Top2b (encoding topoisomerase-II beta) protects cardiomyocytes from doxorubicin-induced DNA double-strand breaks and transcriptome changes that are responsible for defective mitochondrial biogenesis and ROS formation. Furthermore, cardiomyocyte-specific deletion of Top2b protects mice from the development of doxorubicin-induced progressive heart failure, suggesting that doxorubicin-induced cardiotoxicity is mediated by topoisomerase-II beta in cardiomyocytes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据